---
figid: PMC5564037__fig-4
figtitle: Capturing Human Naïve Pluripotency in the Embryo and in the Dish
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC5564037
filename: fig-4.jpg
figlink: /pmc/articles/PMC5564037/figure/f4/
number: F4
caption: 'Schematic summary of four main signaling pathways that regulate the naïve
  pluripotent state. (a) The BMP/SMAD, LIF/STAT3, FGF2/ERK, and WNT/β-catenin pathways
  are the four main molecular axes regulating naïve pluripotency. These circuits not
  only share a few common transcriptional effectors but also act separately to reinforce
  the core pluripotency network through mechanisms that can involve the KLF circuitry.
  Fluctuating subcellular distribution of the WNT pathway effector β-catenin may regulate
  accessibility of the core factors, OCT4 and Nanog, by facilitating their functions
  in either the nucleus or at the cell membrane (eg, to reinforce E-Cadherin strengthening
  of STAT3 signaling). (b) Downstream signaling of BMP/SMAD, WNT/β-catenin, LIF/STAT3,
  or MEK/ERK suppression results in marked reductions of genome-wide chromatin repressive
  marks (ie, reduced DNMT3a/DNMT3b levels and impaired DNMT1 recruitment following
  UHRF1 downregulation) as well as downregulation of lineage priming at developmental
  promoters by mechanisms that involve RNA-pol II pausing and accessibility to the
  PRC2. Green arrows: activation. Red blunt line: inhibition. Proteins known to reinforce
  (green) or destabilize (red) naïve pluripotency are shown. KLF, Krüppel-like factor;
  PRC2, polycomb repressor complex 2.'
papertitle: Capturing Human Naïve Pluripotency in the Embryo and in the Dish.
reftext: Ludovic Zimmerlin, et al. Stem Cells Dev. 2017 Aug 15;26(16):1141-1161.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8176327
figid_alias: PMC5564037__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5564037__F4
ndex: 64d19c10-df1f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5564037__fig-4.html
  '@type': Dataset
  description: 'Schematic summary of four main signaling pathways that regulate the
    naïve pluripotent state. (a) The BMP/SMAD, LIF/STAT3, FGF2/ERK, and WNT/β-catenin
    pathways are the four main molecular axes regulating naïve pluripotency. These
    circuits not only share a few common transcriptional effectors but also act separately
    to reinforce the core pluripotency network through mechanisms that can involve
    the KLF circuitry. Fluctuating subcellular distribution of the WNT pathway effector
    β-catenin may regulate accessibility of the core factors, OCT4 and Nanog, by facilitating
    their functions in either the nucleus or at the cell membrane (eg, to reinforce
    E-Cadherin strengthening of STAT3 signaling). (b) Downstream signaling of BMP/SMAD,
    WNT/β-catenin, LIF/STAT3, or MEK/ERK suppression results in marked reductions
    of genome-wide chromatin repressive marks (ie, reduced DNMT3a/DNMT3b levels and
    impaired DNMT1 recruitment following UHRF1 downregulation) as well as downregulation
    of lineage priming at developmental promoters by mechanisms that involve RNA-pol
    II pausing and accessibility to the PRC2. Green arrows: activation. Red blunt
    line: inhibition. Proteins known to reinforce (green) or destabilize (red) naïve
    pluripotency are shown. KLF, Krüppel-like factor; PRC2, polycomb repressor complex
    2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mdk
  - Ephb2
  - Mapk1
  - Stat3
  - Bmp4
  - Lif
  - Lifr
  - Il11ra1
  - Il6st
  - Lrpprc
  - Lrp5
  - Bmpr1a
  - Cdh1
  - Fzr1
  - Ctnnb1
  - Nanog
  - Pou5f1
  - ras
  - Hras
  - Kras
  - Rem1
  - Shh
  - Apc
  - Axin1
  - Zhx2
  - Gm12892
  - Gsk3b
  - Map2k1
  - Mapk7
  - Akt1
  - Mapk3
  - Tcf3
  - Tcf7l1
  - Sp5
  - Phxr4
  - Sftpc
  - Tfcp2l1
  - Sox2
  - Klf2
  - Klf4
  - Jarid2
  - Cxxc4
  - Dnmt3l
  - Dppa3
  - Dnmt3a
  - Dnmt1
  - Uhrf1
  - Tet1
  - Tet2
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - STAT3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - LIF
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - IL6ST
  - NM
  - LRPPRC
  - LRP5
  - LIFR
  - CDH1
  - FZR1
  - CTNNB1
  - NANOG
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - KRAS
  - HRAS
  - NRAS
  - ADAR
  - DVL1P1
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3B
  - MAPK7
  - AKT1
  - AKT2
  - AKT3
  - MYC
  - TCF3
  - TCF7L1
  - SP5
  - SFTPC
  - TFCP2L1
  - SOX2
  - KLF2
  - KLF4
  - POLR1A
  - POLR1B
  - POLR1C
  - POLR1D
  - JARID2
  - CXXC4
  - EED
  - EZH1
  - EZH2
  - SUZ12
  - DNMT3L
  - DPPA3
  - DPPA3P2
  - DNMT3A
  - DNMT1
  - UHRF1
  - TET1
  - TET2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - Cancer
  - Noonan syndrome
---
